10-QPeriod: Q2 FY2025

Astera Labs, Inc. Quarterly Report for Q2 Ended Jun 30, 2025

Filed August 6, 2025For Securities:ALAB

Summary

Astera Labs, Inc. reported strong revenue growth in its fiscal second quarter of 2025, with a significant 150% increase year-over-year, driven by higher unit shipments and average selling prices across its Aries, Scorpio, and Taurus product lines. Despite this impressive top-line performance, the gross margin saw a slight decrease due to a shift in product mix towards hardware modules. The company also experienced a substantial increase in operating expenses, primarily due to growth in headcount and R&D initiatives aimed at supporting business expansion and product development. Financially, Astera Labs moved from a net loss in the prior year's comparable period to a substantial net income of $51.2 million for the quarter. This turnaround is further highlighted by the positive net cash provided by operating activities, a significant improvement from the previous year. The company maintains a strong liquidity position with over $1 billion in cash, cash equivalents, and marketable securities, which management believes is sufficient for at least the next 12 months. However, the report also notes material weaknesses in internal control over financial reporting, which the company is actively working to remediate.

Financial Highlights

47 data points
Beta

Revenue

$191.93M

75.8% Gross Margin

Net Income

$51.22M

26.7% Net Margin

EPS (Diluted)

$0.29

Total Assets

$1.27B

Cash & Equivalents

$163.40M

Free Cash Flow

$133.34M

Financial Statements
Beta
Revenue$191.93M
Cost of Revenue$46.36M
Gross Profit$145.56M
R&D Expenses$66.72M
Operating Expenses$105.79M
Operating Income$39.77M
Net Income$51.22M
EPS (Basic)$0.31
EPS (Diluted)$0.29
Shares Outstanding (Basic)165.43M
Shares Outstanding (Diluted)178.10M

Key Highlights

  • 1Revenue surged by 150% year-over-year to $191.9 million for Q2 2025, indicating robust demand for Astera Labs' connectivity solutions.
  • 2Gross margin slightly decreased to 75.8% from 77.9% year-over-year, attributed to a shift in product mix toward hardware modules.
  • 3Operating expenses increased by 26% in Q2 2025 compared to the prior year, largely due to a 75% increase in headcount and investments in R&D.
  • 4The company achieved net income of $51.2 million in Q2 2025, a significant improvement from a net loss of $7.5 million in the same period of 2024.
  • 5Net cash provided by operating activities was $145.9 million for the first six months of 2025, a substantial increase from $33.5 million in the prior year's period.
  • 6Total assets grew to $1.27 billion as of June 30, 2025, with cash and marketable securities exceeding $1 billion.
  • 7The company reported material weaknesses in its internal control over financial reporting, stemming from inadequate risk assessment processes and IT general controls, which are currently under remediation.

Frequently Asked Questions

Astera Labs' revenue growth is primarily driven by increased unit shipments, fueled by strong demand for its Aries, Scorpio, and Taurus products. Additionally, higher average selling prices, resulting from a favorable product mix including more hardware modules and Scorpio products, are contributing to the top-line expansion.

The gross margin saw a slight decrease because of a change in product mix. The company is shipping a greater proportion of hardware modules, which have a different cost structure compared to other product types, leading to a lower overall gross margin percentage.

The increase in operating expenses is mainly due to a significant rise in headcount (up 75%) and increased investments in research and development (R&D) to support business expansion and new product initiatives. Other factors include costs associated with relocating to new headquarters and increased professional services fees.

Astera Labs reported a strong balance sheet with total assets of $1.27 billion as of June 30, 2025. The company holds over $1 billion in cash, cash equivalents, and marketable securities, providing substantial liquidity. Management believes these resources are sufficient to fund operations for at least the next 12 months and beyond, though future capital needs may lead to equity or debt financing.

Astera Labs identified material weaknesses related to an insufficient risk assessment process (including control over journal entries and reconciliations) and deficiencies in IT general controls (such as program change management and user access controls). The company is implementing remediation efforts, including engaging external consultants, formalizing accounting policies, hiring additional staff for segregation of duties, and improving IT controls, to address these issues. However, these weaknesses were not considered remediated as of June 30, 2025.